Examination of the effect of BornFree ActiveFlow baby bottles on infant colic

Yaron Tikochinski1, Ida Kukliansky

  • 1Ruppin Academic Center, Michmoret, Israel. yaont@ruppin.ac.il

Insights

Colic symptoms in newborns significantly improved when using BornFree ActiveFlow baby bottles. This study found BornFree bottles effectively reduced infant colic, easing parental burden.

Area of Science:

  • Pediatrics
  • Infant Health
  • Gastroenterology

Background:

  • Infant colic is a common condition causing significant parental distress.
  • Existing feeding bottles may not adequately address colic symptoms.

Purpose of the Study:

  • To evaluate the efficacy of BornFree ActiveFlow baby bottles in reducing colic symptoms in infants.
  • To compare the impact of BornFree bottles versus other brands on infant colic.

Main Methods:

  • A comparative study involving 30 newborns diagnosed with colic (ages 2-21 weeks).
  • An experimental group (20 infants) used BornFree bottles, while a control group (10 infants) used other brands.
  • Observed colic symptoms were monitored over two weeks.

Main Results:

  • The experimental group showed significant improvement in colic symptoms after one week, with further improvement in the second week.
  • The control group exhibited no significant change in colic symptoms throughout the study.
  • BornFree bottles demonstrated a clear positive effect on reducing infant colic.

Conclusions:

  • BornFree ActiveFlow baby bottles are effective in reducing colic symptoms in diagnosed infants.
  • The study suggests a potential benefit of specialized bottle design in managing infant colic.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
670
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
911
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
975